<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Koide K</submitter><funding>NICHD NIH HHS</funding><pagination>295-305</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3206603</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>129(3)</volume><pubmed_abstract>Trisomy 18 is a common human aneuploidy that is associated with significant perinatal mortality. Unlike the well-characterized "critical region" in trisomy 21 (21q22), there is no corresponding region on chromosome 18 associated with its pathogenesis. The high morbidity and mortality of affected individuals has limited extensive investigations. In order to better understand the molecular mechanisms underlying the congenital anomalies observed in this condition, we investigated the in utero gene expression profile of second trimester fetuses affected with trisomy 18. Total RNA was extracted from cell-free amniotic fluid supernatant from aneuploid fetuses and euploid controls matched for gestational age and hybridized to Affymetrix U133 Plus 2.0 arrays. Individual differentially expressed tr</pubmed_abstract><journal>Human genetics</journal><pubmed_title>Transcriptomic analysis of cell-free fetal RNA suggests a specific molecular phenotype in trisomy 18.</pubmed_title><pmcid>PMC3206603</pmcid><funding_grant_id>R01 HD 042053-07</funding_grant_id><funding_grant_id>R01 HD042053</funding_grant_id><funding_grant_id>R01 HD058880</funding_grant_id><funding_grant_id>R01 HD 058880-01</funding_grant_id><funding_grant_id>R01 HD058880-03</funding_grant_id><pubmed_authors>Johnson KL</pubmed_authors><pubmed_authors>Koide K</pubmed_authors><pubmed_authors>Cowan JM</pubmed_authors><pubmed_authors>Slonim DK</pubmed_authors><pubmed_authors>Bianchi DW</pubmed_authors><pubmed_authors>Tantravahi U</pubmed_authors></additional><is_claimable>false</is_claimable><name>Transcriptomic analysis of cell-free fetal RNA suggests a specific molecular phenotype in trisomy 18.</name><description>Trisomy 18 is a common human aneuploidy that is associated with significant perinatal mortality. Unlike the well-characterized "critical region" in trisomy 21 (21q22), there is no corresponding region on chromosome 18 associated with its pathogenesis. The high morbidity and mortality of affected individuals has limited extensive investigations. In order to better understand the molecular mechanisms underlying the congenital anomalies observed in this condition, we investigated the in utero gene expression profile of second trimester fetuses affected with trisomy 18. Total RNA was extracted from cell-free amniotic fluid supernatant from aneuploid fetuses and euploid controls matched for gestational age and hybridized to Affymetrix U133 Plus 2.0 arrays. Individual differentially expressed tr</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Mar</publication><modification>2025-05-18T10:45:11.1Z</modification><creation>2025-05-18T10:45:11.1Z</creation></dates><accession>S-EPMC3206603</accession><cross_references><pubmed>21152935</pubmed><doi>10.1007/s00439-010-0923-3</doi></cross_references></HashMap>